NuCana plc - American Depositary Share (NCNA) Social Stream



NuCana plc - American Depositary Share (NCNA): $1.50

0.05 (-3.23%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add NCNA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#306 of 333

in industry

NUCANA PLC (NCNA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering NUCANA PLC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-23 6 $22 $10 $18 $0.295 6001.69%
2021-11-24 6 $22 $9 $17.75 $0.295 5916.95%
2022-03-14 5 $22 $5 $14.25 $0.295 4730.51%
2022-06-05 5 $21 $5 $10.25 $0.295 3374.58%
2022-08-17 5 $21 $5 $10.666 $0.295 3515.59%
2022-08-22 4 $21 $5 $10.666 $0.295 3515.59%
2022-11-16 5 $6 $3 $4.666 $0.295 1481.69%
2023-04-04 4 $6 $3 $4.333 $0.295 1368.81%
2023-08-20 5 $6 $3 $4.333 $0.295 1368.81%
2023-10-17 5 $6 $4 $5 $0.295 1594.92%
2023-11-21 4 $6 $4 $5 $0.295 1594.92%

The Trend in the Analyst Price Target


NCNA's average price target has moved down $13 over the prior 27 months.

Over the past 36 weeks, NCNA's average upside potential has been 536%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-04-04 4 6 3 4.333 0.880 392.39%
2023-05-23 5 6 3 4.333 0.900 381.44%
2023-08-20 5 6 3 4.333 0.750 477.73%
2023-10-17 4 6 4 5.000 0.659 658.73%
2023-11-21 4 6 4 5.000 0.410 1119.51%

NCNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


Over the past 45 months, NCNA's average broker recommendation rating worsened by 0.5.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NCNA as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, NUCANA PLC's upside potential (average analyst target price relative to current price) is higher than 1188.17% of them.
  • In the context of all US stocks, NUCANA PLC's average analyst price target is greater than 135.58% of them.
  • NUCANA PLC's number of analysts covering the stock is greater than 293.88% of Healthcare stocks.
  • NCNA has a lower variance in analysts' estimates than -796.3% of stocks in the small market cap category.

In the Pharmaceutical Products industry, KALA, ATHE, and VRNA are the three stocks most similar to NUCANA PLC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding NCNA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!